TY - JOUR
T1 - Effect of BDNF Val66Met on hippocampal subfields volumes and compensatory interaction with APOE-ε4 in middle-age cognitively unimpaired individuals from the ALFA study
AU - for the ALFA Study
AU - Vilor-Tejedor, Natalia
AU - Operto, Grégory
AU - Evans, Tavia E.
AU - Falcon, Carles
AU - Crous-Bou, Marta
AU - Minguillón, Carolina
AU - Cacciaglia, Raffaele
AU - Milà-Alomà, Marta
AU - Grau-Rivera, Oriol
AU - Suárez-Calvet, Marc
AU - Garrido-Martín, Diego
AU - Morán, Sebastián
AU - Esteller, Manel
AU - Adams, Hieab H.
AU - Molinuevo, José Luis
AU - Guigó, Roderic
AU - Gispert, Juan Domingo
N1 - Funding Information:
NV-T is funded by a post-doctoral grant, Juan de la Cierva Programme (FJC2018-038085-I), Ministerio de Ciencia, Innovación y Universidades – Spanish State Research Agency. The research leading to these results has received funding from “la Caixa” Foundation (LCF/PR/GN17/10300004) and the Health Department of the Catalan Government (Health Research and Innovation Strategic Plan (PERIS) 2016–2020 grant# SLT002/16/00201). CM was supported by the Spanish Ministry of Economy and Competitiveness (grant n° IEDI-2016-00690). MSC received funding from the European Union’s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie action grant agreement No 752310. H.H.H.A. was supported by ZonMW grant numbers 916.19.15 and 916.19.151. J.D.G. holds a ‘Ramón y Cajal’ fellowship (RYC-2013-13054). This publication is part of the ALFA (ALzheimer and FAmilies) study. The authors would like to express their most sincere gratitude to the ALFA project participants, without whom this research would have not been possible. With recognition and heartfelt gratitude to Mrs. Blanca Brillas for her outstanding and continued support to the Pasqual Maragall Foundation to make possible a Future without Alzheimer´s. Collaborators of the ALFA study are: Eider M. Arenaza-Urquijo, Annabella Beteta, Anna Brugulat-Serrat, Alba Cañas, Carme Deulofeu, Ruth Dominguez, Maria Emilio, Karine Fauria, Sherezade Fuentes, Laura Hernandez, Gema Huesa, Jordi Huguet, Paula Marne, Tania Menchón, Albina Polo, Sandra Pradas, Aleix Sala-Vila, Gonzalo Sánchez-Benavides, Anna Soteras, Gemma Salvadó, Mahnaz Shekari, Marc Vilanova.
Funding Information:
NV-T is funded by a post-doctoral grant, Juan de la Cierva Programme (FJC2018-038085-I), Ministerio de Ciencia, Innovaci?n y Universidades ? Spanish State Research Agency. The research leading to these results has received funding from ?la Caixa? Foundation (LCF/PR/GN17/10300004) and the Health Department of the Catalan Government (Health Research and Innovation Strategic Plan (PERIS) 2016?2020 grant# SLT002/16/00201). CM was supported by the Spanish Ministry of Economy and Competitiveness (grant n? IEDI-2016-00690). MSC received funding from the European Union?s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie action grant agreement No 752310. H.H.H.A. was supported by ZonMW grant numbers 916.19.15 and 916.19.151. J.D.G. holds a ?Ram?n y Cajal? fellowship (RYC-2013-13054). This publication is part of the ALFA (ALzheimer and FAmilies) study. The authors would like to express their?most sincere gratitude to the ALFA project participants, without whom this research would have not been possible. With recognition and heartfelt gratitude to Mrs. Blanca Brillas for her outstanding and continued support to the Pasqual Maragall Foundation to make possible a Future without Alzheimer?s. Collaborators of the ALFA study are: Eider M. Arenaza-Urquijo, Annabella Beteta, Anna Brugulat-Serrat, Alba Ca?as, Carme Deulofeu, Ruth Dominguez, Maria Emilio, Karine Fauria, Sherezade Fuentes, Laura Hernandez, Gema Huesa, Jordi Huguet, Paula Marne, Tania Mench?n, Albina Polo, Sandra Pradas, Aleix Sala-Vila, Gonzalo S?nchez-Benavides, Anna Soteras, Gemma Salvad?, Mahnaz Shekari, Marc Vilanova.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Background: Current evidence supports the involvement of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism, and the ε4 allele of APOE gene in hippocampal-dependent functions. Previous studies on the association of Val66Met with whole hippocampal volume included patients of a variety of disorders. However, it remains to be elucidated whether there is an impact of BDNF Val66Met polymorphism on the volumes of the hippocampal subfield volumes (HSv) in cognitively unimpaired (CU) individuals, and the interactive effect with the APOE-ε4 status. Methods: BDNF Val66Met and APOE genotypes were determined in a sample of 430 CU late/middle-aged participants from the ALFA study (ALzheimer and FAmilies). Participants underwent a brain 3D-T1-weighted MRI scan, and volumes of the HSv were determined using Freesurfer (v6.0). The effects of the BDNF Val66Met genotype on the HSv were assessed using general linear models corrected by age, gender, education, number of APOE-ε4 alleles and total intracranial volume. We also investigated whether the association between APOE-ε4 allele and HSv were modified by BDNF Val66Met genotypes. Results: BDNF Val66Met carriers showed larger bilateral volumes of the subiculum subfield. In addition, HSv reductions associated with APOE-ε4 allele were significantly moderated by BDNF Val66Met status. BDNF Met carriers who were also APOE-ε4 homozygous showed patterns of higher HSv than BDNF Val carriers. Conclusion: To our knowledge, the present study is the first to show that carrying the BDNF Val66Met polymorphisms partially compensates the decreased on HSv associated with APOE-ε4 in middle-age cognitively unimpaired individuals.
AB - Background: Current evidence supports the involvement of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism, and the ε4 allele of APOE gene in hippocampal-dependent functions. Previous studies on the association of Val66Met with whole hippocampal volume included patients of a variety of disorders. However, it remains to be elucidated whether there is an impact of BDNF Val66Met polymorphism on the volumes of the hippocampal subfield volumes (HSv) in cognitively unimpaired (CU) individuals, and the interactive effect with the APOE-ε4 status. Methods: BDNF Val66Met and APOE genotypes were determined in a sample of 430 CU late/middle-aged participants from the ALFA study (ALzheimer and FAmilies). Participants underwent a brain 3D-T1-weighted MRI scan, and volumes of the HSv were determined using Freesurfer (v6.0). The effects of the BDNF Val66Met genotype on the HSv were assessed using general linear models corrected by age, gender, education, number of APOE-ε4 alleles and total intracranial volume. We also investigated whether the association between APOE-ε4 allele and HSv were modified by BDNF Val66Met genotypes. Results: BDNF Val66Met carriers showed larger bilateral volumes of the subiculum subfield. In addition, HSv reductions associated with APOE-ε4 allele were significantly moderated by BDNF Val66Met status. BDNF Met carriers who were also APOE-ε4 homozygous showed patterns of higher HSv than BDNF Val carriers. Conclusion: To our knowledge, the present study is the first to show that carrying the BDNF Val66Met polymorphisms partially compensates the decreased on HSv associated with APOE-ε4 in middle-age cognitively unimpaired individuals.
KW - APOE-ε4
KW - BDNF
KW - Hippocampal subfields
KW - Imaging genetics
KW - Subiculum
KW - Val66Met
UR - http://www.scopus.com/inward/record.url?scp=85089472649&partnerID=8YFLogxK
U2 - 10.1007/s00429-020-02125-3
DO - 10.1007/s00429-020-02125-3
M3 - Article
C2 - 32804326
AN - SCOPUS:85089472649
SN - 1863-2661
VL - 225
SP - 2331
EP - 2345
JO - Brain structure & function
JF - Brain structure & function
IS - 8
ER -